The Cost-Effectiveness of Continuous Erythropoiesis Receptor Activator Once Monthly versus Epoetin Thrice Weekly for Anaemia Management in Chronic Haemodialysis Patients

Figure 6

Probabilistic sensitivity analysis of ICER distribution of CERA versus EpoB. The analysis confirmed the robustness of the model, based on 50 000 random iteration; the ICER remain within the range of calculated ICER ± 10%.